Chen L et al.HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.Cell Death Dis 9:513 (2018).
Uthamalingam P et al.Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.J Clin Exp Hepatol 8:173-180 (2018).
Sheppard S et al.The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.Nat Commun 8:13930 (2017).
Shalini S et al.Caspase-2 deficiency accelerates chemically induced liver cancer in mice.Cell Death Differ 23:1727-36 (2016).
Qi X et al.Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.J Clin Cell Immunol 7:N/A (2016).
Luo W et al.Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma.Oncol Lett 11:1345-1352 (2016).
Lai MW et al.Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation.Oncogenesis 5:e273 (2016).
Luo C et al.GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.Oncol Rep 32:913-21 (2014).
Runge A et al.An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.Cancer Res 74:4157-69 (2014).
Takakura K et al.Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice.Anticancer Res 34:4849-55 (2014).